A compassionate use program in cystic fibrosis patients with non-tuberculous mycobacteria (NTM) Infection
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 19 Sep 2017
At a glance
- Drugs Nitric oxide (Primary)
- Indications Cystic fibrosis
- Focus Expanded access; Therapeutic Use
- 19 Sep 2017 New trial record
- 13 Sep 2017 Results published in an AIT Therapeutics media release.
- 13 Sep 2017 According to an AIT Therapeutics media release, results from the study have been published in the peer-reviewed Pediatric Infectious Disease Journal.